Created in November 2020, the start-up Genexpath is in the industrialization phase of diagnostic kits for certain cancers. Juliette Renauld, the manager, hopes to be able to market them at the end of the spring.

In the premises of the Genexpath start-up, near the Jardin des Plantes in Rouen, the boxes bear witness to the recent installation of Juliette Renauld and her team. The young company, created in November 2020 and incubated by Normandie Incubation, develops diagnostic kits for certain cancers, particularly lymphomas (tumors of the lymphatic system) and sarcomas (rare cancer of soft tissues, bones and cartilages, which affects many children).